a bit sad with rollout, i hopein the back ground those kids that needed the treatment were still getting it un expanded use.
hard to read between the lines about whether this is happening, lots of chatter about how much? and profit margins etc. happy to see the cost saving against prior standard of care, saving insurance etc millions
cost of application to me seem mute, as i think we have stock piles, and there were lots of cost (loss) mentioned too, so would think our margins ie porfit would be very high as already accounted for? next year - maybe cost of doing business might rise, should rise. personally i have a tear in the eye, thinking about the kids and families
MSB Price at posting:
$2.70 Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)